doxazosin treatment chronic congest heart failur result random double-blind placebo-control studi studi effect once-daili administr oral doxazosin patient chronic congest heart failur chf stabil period week digitali diuret patient chronic chf doxazosin placebo double-blind fashion patient underw weekli dose adjust dose doxazosin mg placebo week addit week dose studi drug treatment group respect symptom heart failur index qualiti life ventricular function frequenc type arrhythmia advers event mortal rate doxazosin mg favor trend investig patient assess symptomat chang doxazosin level voluntari submaxim exercis favor trend left ventricular eject fraction increas baselin valu placebo NS steady-dos period patient doxazosin signific reduct ventricular arrhythmia morbid mortal cardiac event episod heart failur sever discontinu studi myocardi infarct death doxazosin major side effect frequenc minor treatment-rel side effect placebo NS 